Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Ishares A.I. Innovation and Tech Active ETF (BAI)

Ishares A.I. Innovation and Tech Active ETF (BAI)
26.98 -0.38 (-1.39%) 12:28 ET [NYSE Arca]
26.96 x 1 27.00 x 3
Realtime by (Cboe BZX)
26.96 x 1 27.00 x 3
Realtime - - (-) -
News & Headlines for Mon, Feb 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
DeepSeek Shakes US Tech Dominance: Impact on Stocks & ETFs

The technology sector, which had been enjoying a huge AI boom, saw a bloodbath on Monday, triggered by the emergence of DeepSeek, a China-based artificial intelligence (AI) startup that threatens to disrupt...

NVDA : 134.34 (-0.07%)
DAPP : 13.05 (-3.62%)
SMCL : 36.75 (-7.03%)
PSI : 58.70 (-0.66%)
SEMI : 26.35 (+0.15%)
ARTY : 38.30 (-1.54%)
BAI : 26.98 (-1.41%)
AIS : 25.25 (-1.92%)
TSMY : 17.07 (-1.40%)
SMHX : 28.37 (-0.73%)
SMH : 248.78 (-0.48%)
SHOC : 47.16 (-0.23%)
BenevolentAI: Notice of Preliminary Results

BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI), a leading, clinical-stage AI-enabled drug discovery company, will announce its preliminary results for the year ended 31...

BAI : 26.98 (-1.41%)
BenevolentAI to Present at the Cowen 43rd Annual Health Care Conference

BenevolentAI ​​(Euronext Amsterdam: BAI), a leading clinical-stage AI drug discovery company, announces that it will present at the Cowen 43rd Annual Health Care Conference, which will be held in Boston...

BAI : 26.98 (-1.41%)
BenevolentAI to Present at 41st Annual J.P. Morgan Healthcare Conference

BenevolentAI ​​(Euronext Amsterdam: BAI), a leading clinical-stage AI drug discovery company, announces that it will participate in the upcoming 41st Annual J.P. Morgan Healthcare Conference in San...

BAI : 26.98 (-1.41%)
BenevolentAI Group: Analyst / Investor Event and Interim Results

/PRNewswire/ -- BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leading, clinical-stage AI-enabled drug discovery company, is...

BAI : 26.98 (-1.41%)
BenevolentAI Group: Notice of Interim Results and Analyst / Investor Event

/PRNewswire/ -- BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leading, clinical-stage AI-enabled drug discovery company, will...

BAI : 26.98 (-1.41%)

Barchart Exclusives

Nvidia Stock: UBS Expects ‘Strong Results’ When the Company Reports Q4 Earnings
Analyst Timothy Arcuri believes the chip giant's results will exceed expectations. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Mastering Fibonacci: The Hidden Order in Market Movements